References
- Chapman JS, Georgopapadakou NH. Routes of quinolone permeation in Escherichia coli. Antimicrob Agents Chemother. 1988. 32: 438-442. https://doi.org/10.1128/AAC.32.4.438
- Chen CZ, Cooper SL. Interactions between dendrimer biocides and bacterial membranes. Biomaterials 2002. 3359-3368.
- Danese PN. Antibiofilm approaches: Prevention of catheter colonization. Chem Biol. 2002. 9: 873-880. https://doi.org/10.1016/S1074-5521(02)00192-8
- Dougherty TJ, Saukkonen JJ. Membrane permeability changes associated with DNA gyrase inhibitors in Escherichia coli. Antimicrob Agents Chemother. 1985. 28: 200-206. https://doi.org/10.1128/AAC.28.2.200
- Elliott TSJ, Shelton A, Greenwood D. The response of Escherichia coli to ciprofloxacin and norfloxacin. J Med Microbiol. 1987. 23: 83-88. https://doi.org/10.1099/00222615-23-1-83
- Falagas ME, Fragoulis K, Bliziotis IA, Chatzinikolaou I. Rifampicinimpregnated central venous catheters: a meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2007. 59: 359-369. https://doi.org/10.1093/jac/dkl522
- Hockenhull JC, Dwan K, Boland A, Smith G, Bagust A, Dündar Y, Gamble C, McLeod C, Walley T, Dickson R. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technol Assess. 2008. 12: 1-154.
- Jeon SM, Kim MN. Prevention of catheter-related infections (CRIs) using ciprofloxacin. J Exp Biomed Sci. 2004. 10: 245 -251.
- Jeon SM, Kim MN. In vitro retention of antimicrobial activity of ciprofloxacin-incorporated central venous catheters. J Exp Biomed Sci. 2007. 13: 175-182.
- Khare MD, Bukhari SS, Swann A, Spiers P, McLaren I, Myers J. Reduction of catheter-related colonisation by the use of a silver zeolite-impregnated central vascular catheter in adult critical care. 2007. J Infect. 54: 146-150. https://doi.org/10.1016/j.jinf.2006.03.002
- Kim TW, Kim YK, Kwon HC, Park KH, Park SW, Baek TH, Lee YA, Yoon ES. Medical Microorganisms and Infectious Diseases. 2007. pp 45-46. SooMoonSa Publishing. Seoul, Korea.
- KSM. Testing methods for antibacterial activity of antibacterial functional products. Part 1: Shake flask method. KSM. 2003. KSM 0146.
- Leduc M, Kasra R, Heijenoort JV. Induction and control of the autolytic system of Escherichia coli. J Bacteriol. 1982. 152: 26-34.
-
Lim KM, Seo YH, Shin JO, Lee HY, Jeong IS, Jo EH, Ha YM. Microbiology (
$5^{th}$ ed.). 2003. pp 54-56. Life Science Publication,Co. Seoul, Korea. -
Madigan MT, Martinko JM, Parker J. Brock Biology of Microorganisms (
$10^{th}$ ed.). 2003. pp 704-705. Pearson Education, Inc. NJ, USA. - Mason DJ, Power EGM, Talsania H, Philips I, Gant VA. Antibacterial action of ciprofloxacin. Antimicrob Agents Chemother. 1995. 39: 2752-2758. https://doi.org/10.1128/AAC.39.12.2752
- Mermel LA, DO, ScM, AM(Hon). Prevention of intravascular catheter-related infections. Ann Intern Med. 2000. 132: 391 -402. https://doi.org/10.1001/archinte.132.3.391
- Mermel LA. New technologies to prevent intravascular catheterrelated bloodstream infections. Emerg Infect Dis. 2001. 7: 197-198. https://doi.org/10.3201/eid0702.010208
- Moon WS, Chung KH, Seol DJ, Park ES, Shim JH, Kim MN, Yoon JS. J Appl Polym Sci. 2003. 90: 2933-2937. https://doi.org/10.1002/app.13019
- Park ES, Kim HS, Kim MN, Yoon JS. Antibacterial activities of polystyrene-block-poly(4-vinyl pyridine) and poly(styrenerandom- 4-vinyl pyridine). Eur Polym J. 2004. 40: 2819-2822. https://doi.org/10.1016/j.eurpolymj.2004.07.025
- Ramritu P, Halton K, Collignon P, Cook D, Fraenkel D, Battistutta D, Whitby M, Graves N. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. Am J Infect Control. 2008. 36: p104-117 https://doi.org/10.1016/j.ajic.2007.02.012
- Rupp ME, Lisco SJ, Lipsett PA, Perl TM, Keating K, Civetta JM, Mermel LA, Lee D, Dellinger EP, Donahoe M, Giles D, Pfaller MA, Maki DG, Sherertz R. Effect of a secondgeneration venous catheter impregnated with chlorhexidine and silvers sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med. 2005. 143: 570-580. https://doi.org/10.1001/archinte.143.3.570
- Song MJ, Kim MN. Antimicrobial action of p-hydroxyphenyl acrylate. Int Biodeterior Biodegradation 2003. 52: 107-113. https://doi.org/10.1016/S0964-8305(03)00032-5
- Polderman KH, Girbes ARJ. Central venous catheter use. Part1: Mechanical complications. Intensive Care Med. 2002. 28: 1-7. https://doi.org/10.1007/s00134-001-1154-9
- Raad I. Pathogenesis of intravascular-catheter-related infections. The Lancet 1998. 351: 893-898. https://doi.org/10.1016/S0140-6736(97)10006-X
-
Russell AD, Chopra I. Understanding Antitimicrobial Action and Resistance (
$2^{nd} ed$ ). 1996. pp 85-110. Ellis Horwood, Ltd. Maylands, England. - Yorganci K, Krepel C, Weigelt JA, Edmiston CE. In vitro evaluation of the antibacterial activity of three different central venous catheters against gram-positive bacteria. Eur J Clin Microbial Infect Dis. 2002. 21: 379-384. https://doi.org/10.1007/s10096-002-0719-z